200 related articles for article (PubMed ID: 10934055)
1. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.
Paredi P; Kharitonov SA; Leak D; Ward S; Cramer D; Barnes PJ
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):369-73. PubMed ID: 10934055
[TBL] [Abstract][Full Text] [Related]
2. Elevation of exhaled ethane concentration in asthma.
Paredi P; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1450-4. PubMed ID: 11029360
[TBL] [Abstract][Full Text] [Related]
3. Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction.
Paredi P; Kharitonov SA; Leak D; Shah PL; Cramer D; Hodson ME; Barnes PJ
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1247-51. PubMed ID: 10764319
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expired air for oxidation products.
Paredi P; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S31-7. PubMed ID: 12471086
[TBL] [Abstract][Full Text] [Related]
5. Exhaled nitric oxide in chronic obstructive pulmonary disease.
Maziak W; Loukides S; Culpitt S; Sullivan P; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):998-1002. PubMed ID: 9517624
[TBL] [Abstract][Full Text] [Related]
6. Exhaled carbon monoxide and nitric oxide in COPD.
Montuschi P; Kharitonov SA; Barnes PJ
Chest; 2001 Aug; 120(2):496-501. PubMed ID: 11502649
[TBL] [Abstract][Full Text] [Related]
7. Increased carbon monoxide in exhaled air of patients with cystic fibrosis.
Paredi P; Shah PL; Montuschi P; Sullivan P; Hodson ME; Kharitonov SA; Barnes PJ
Thorax; 1999 Oct; 54(10):917-20. PubMed ID: 10491455
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia.
Puri BK; Ross BM; Treasaden IH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):858-62. PubMed ID: 18262322
[TBL] [Abstract][Full Text] [Related]
9. Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases.
Kanoh S; Kobayashi H; Motoyoshi K
Chest; 2005 Oct; 128(4):2387-92. PubMed ID: 16236899
[TBL] [Abstract][Full Text] [Related]
10. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
Montuschi P; Corradi M; Ciabattoni G; Nightingale J; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):216-20. PubMed ID: 10390403
[TBL] [Abstract][Full Text] [Related]
11. Normal bronchial blood flow in COPD is unaffected by inhaled corticosteroids and correlates with exhaled nitric oxide.
Paredi P; Ward S; Cramer D; Barnes PJ; Kharitonov SA
Chest; 2007 Apr; 131(4):1075-81. PubMed ID: 17426212
[TBL] [Abstract][Full Text] [Related]
12. Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.
Machado RF; Stoller JK; Laskowski D; Zheng S; Lupica JA; Dweik RA; Erzurum SC
J Appl Physiol (1985); 2002 Dec; 93(6):2038-43. PubMed ID: 12391056
[TBL] [Abstract][Full Text] [Related]
13. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia.
Al-Ali MK; Howarth PH
Saudi Med J; 2001 Mar; 22(3):249-53. PubMed ID: 11307112
[TBL] [Abstract][Full Text] [Related]
14. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
15. Study of ethane level in exhaled breath in patients with age-related macular degeneration: preliminary study.
Cagini C; Giordanelli A; Fiore T; Giardinieri R; Malici B; De Medio GE; Pelli MA; De Bellis F; Capodicasa E
Ophthalmic Res; 2011; 46(3):141-4. PubMed ID: 21336004
[TBL] [Abstract][Full Text] [Related]
16. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.
Kharitonov SA; Barnes PJ
Proc Am Thorac Soc; 2004; 1(3):191-9. PubMed ID: 16113434
[TBL] [Abstract][Full Text] [Related]
17. Exhaled hydrogen sulfide in patients with chronic obstructive pulmonary disease and its correlation with exhaled nitric oxide.
Sun Y; Wang XM; Chen YH; Zhu RX; Liao CC
Chin Med J (Engl); 2013; 126(17):3240-4. PubMed ID: 24033943
[TBL] [Abstract][Full Text] [Related]
18. Exhaled nitric oxide from lung periphery is increased in COPD.
Brindicci C; Ito K; Resta O; Pride NB; Barnes PJ; Kharitonov SA
Eur Respir J; 2005 Jul; 26(1):52-9. PubMed ID: 15994389
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
20. Effect of maximal dynamic exercise on exhaled ethane and carbon monoxide levels in human, equine, and canine athletes.
Wyse C; Cathcart A; Sutherland R; Ward S; McMillan L; Gibson G; Padgett M; Skeldon K
Comp Biochem Physiol A Mol Integr Physiol; 2005 Jun; 141(2):239-46. PubMed ID: 15985382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
